<DOC>
	<DOCNO>NCT00435409</DOCNO>
	<brief_summary>The treatment receive sunitinib plus capecitabine could delay tumor growth longer treatment capecitabine alone .</brief_summary>
	<brief_title>A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Sunitinib</mesh_term>
	<criteria>Locally advanced metastatic disease measure . Patients boneonly disease also allow enter study . Previous treatment anthracycline taxane set Progression first second line regimen adjuvant regimen disease free interval le 12 month History inflammatory carcinoma measurable disease More 2 chemotherapy agent advanced disease set Brain metastasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>